Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Jun 15, 2025; 17(6): 107980
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107980
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.107980
Figure 3 Effects of different fibrinogen to albumin on the long-term prognosis of gastric cancer patients.
A: Kaplan-Meier plot of the fibrinogen-to-albumin ratio (FAR) < 0.08 and FAR ≥ 0.08 groups; B: Kaplan-Meier plot of overall survival in the FAR < 0.08 and FAR ≥ 0.08 groups. FAR: Fibrinogen-to-albumin ratio; HR: Hazard ratio.
- Citation: Yao ZY, Liu J, Ma X, Li WT, Shen Y, Cui YZ, Fang Y, Han ZX, Yang CH. Impact of fibrinogen-to-albumin ratio on the long-term prognosis of patients with advanced HER2-negative gastric cancer receiving immunochemotherapy. World J Gastrointest Oncol 2025; 17(6): 107980
- URL: https://www.wjgnet.com/1948-5204/full/v17/i6/107980.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.107980